Vaccine Tag

[wpseo_breadcrumb]

Vaccinations are a critical way to keep yourself and the public at large healthy.

However, vaccinations often come with questions, particularly for new diseases. This article helps answer some of those questions, compiling expert guidance from the Centers for Disease Control and Prevention (CDC).

Before Getting Your Vaccine

It’s important to know whether the COVID-19 vaccination is recommended for you before making any further decisions. This CDC webpage explains who should be vaccinated first. Use the link to see the specific rollout timeline for your state, as it will vary by location. It’s also worth doing a little research on the available vaccines, including how they work and their benefits.

News Brief header The Centers for Disease Control and Prevention (CDC) has released new guidance for people who have been fully vaccinated with a COVID-19 vaccine.

Such individuals have been given the go-ahead to resume many activities that have been on hold since the beginning of the pandemic.

What’s Changed

According to the CDC, people are considered fully vaccinated two weeks after their second dose in a two-dose series, like the Pfizer-BioNTech or Moderna vaccines, or two weeks after a single-dose vaccine, like Johnson & Johnson’s vaccine. According to the guidance, people who have been fully vaccinated:

News Brief header President Joe Biden recently announced that he is directing the U.S. Department of Health and Human Services to purchase an additional 100 million doses of the Johnson & Johnson COVID-19 vaccine.

The White House had announced earlier in March that drugmaker Merck & Co. will help produce competitor Johnson & Johnson’s COVID-19 vaccine to expand its production and supply. The administration invoked the Defense Production Act to get two Merck facilities up to the standards necessary to safely manufacture the Johnson & Johnson vaccine. However, it will take months to fully equip these plants.

Legal Update Header On Feb. 26, 2021, the Departments of Labor, Health and Human Services (HHS), and the Treasury issued FAQ guidance to clarify health coverage requirements related to COVID-19.

Coverage of COVID-19 Diagnostic Testing

Health plans and issuers must cover COVID-19 diagnostic items and services without cost-sharing. The FAQs explain that plans and issuers:

After you’ve received your COVID-19 vaccination, it’s normal to wonder what’s next.

Many questions exist, such as whether you can contract COVID-19 again, what safety precautions you should continue and when life might go back to normal. While a COVID-19 vaccination is a critical step toward returning to a sense of normalcy, it’s important to continue to prioritize the safety of yourself and those around you.

News Brief header The White House recently announced that drugmaker Merck & Co., will help produce competitor Johnson & Johnson’s COVID-19 vaccine to expand its production and supply.

President Joe Biden’s administration will play a key role in this partnership. The administration has invoked the Defense Production Act to get two Merck facilities up to the standards necessary to safely manufacture the Johnson & Johnson vaccine. While it will take months to fully equip these plants, Merck has extensive experience and capacity as a vaccine producer and is prepared to use these two facilities to vastly increase supply.  

News Brief header The U.S. Food and Drug Administration (FDA) recently issued an Emergency Use Authorization (EUA) for Johnson & Johnson’s COVID-19 vaccine to be distributed in the United States for use by individuals 18 years of age and older.

This authorization follows a recommendation from the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) to issue a EUA for the vaccine, and confirms that Americans will have access to a third effective coronavirus vaccine that will allow states to increase distribution.